CattadoriGSeguriniCAgostoniPet al.A medicine for tall, white, blond-haired and blue-eyed, middle-aged, physically active, rich males?Eur J Prev Cardiol2018; 25: 1152–1155.
2.
GronhojMHGerkeOMickleyHet al.External validity of a cardiovascular screening including a coronary artery calcium examination in middle-aged individuals from the general population. Eur J Prev Cardiol2018; 25: 1156–1166.
3.
LeykinYDunnLBMunozRF. The effect of depression on the decision to join a clinical trial. J Consult Clin Psychol2017; 85: 751–756.
4.
AlmeidaLKashdanTBNunesTet al.Who volunteers for phase I clinical trials? Influences of anxiety, social anxiety and depressive symptoms on self-selection and the reporting of adverse events. Eur J Clin Pharmacol2008; 64: 575–582.
5.
PravettoniGMazzoccoKGoriniAet al.Understanding cognitive processes behind acceptance or refusal of phase I trials. Crit Rev Oncol Hematol2016; 100: 69–73.
6.
PiepoliMFHoesAWAgewallSet al.2016 European guidelines on cardiovascular disease prevention in clinical practice. Eur J Prev Cardiol2016; 11: NP1–NP96.
